✦ LIBER ✦

Localized non-Hodgkin's lymphoma of the breast

✍ Scribed by Mitchell R. Smith; Sheryl Brustein; David J. Straus

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 331 KB
Volume: 59
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19870115)59:2<351::aid-cncr2820590231>3.0.co;2-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Localized non-Hodgkin lymphoma involving

Localized non-Hodgkin lymphoma involving the thyroid gland

✍ Chul S. Ha; Kathleen M. Shadle; L. Jeffrey Medeiros; Richard B. Wilder; Mark A. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

Treatment of localized non-Hodgkin's lym

Treatment of localized non-Hodgkin's lymphomas of the head and neck

✍ Cornelis D. M. Ruijs; Adriaan W. Dekker; M. Loes Van Kempen-Harteveld; Joop Van 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 1 views

The treatment of non-Hodgkin's lymphoma

✍ Samuel Hellman; David S. Rosenthal; William C. Moloney; John T. Chaffey 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 1 views

Much of the approach to evaluation and management of the non-Hodgkin's lymphomas has been modeled after Hodgkin's disease. However, as the name implies, they are quite different. The non-Hodgkin's lymphomas are a group of diseases and syndromes. These many different presentations, syndromes, and pos

Extranodal non-Hodgkin's lymphoma

✍ Salitha Reddy; Edmund Pellettiere; Virendra Saxena; Frank R. Hendrickson 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 1 views

Non-Hodgkin lymphoma of the prostate

✍ John Steuter; Dennis D. Weisenburger; R. Greg Bociek; Philip Bierman; Julie Vose 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB

Interferon therapy of non-Hodgkin's lymp

Interferon therapy of non-Hodgkin's lymphoma

✍ Kenneth A. Foon; Mark S. Roth; Paul A. Bunn Jr 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 1 views

In 1981, the National Cancer Institute undertook Phase I1 trials of interferon alfa-2a in patients with non-Hodgkin's lymphoma (including cutaneous T-cell lymphoma [CTCL]) and chronic lymphocytic leukemia (CLL). A dose of 50 X lo6 U/m2, three times per week, was used initially, then adjusted downwar